Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 2 Date: 06 Sep 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Changes are done, accepted for publication
Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 2 Date: 06 Sep 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Changes are done, accepted for publication
Please review this paper.
user
Title: Integrin #5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis
and immunotherapy efficacy in gastric cancer
Version: 2 Date: 06 Sep 2024
Reviewer:  Anwar Abouelnasr
Reviewer's report:
Changes are done, accepted for publication
assistant